Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × Vemurafenib × 1 year × Clear all

Sponsor

Conditions

Melanoma 8 Neoplasms 7 Thyroid Neoplasms 4 Thyroid Cancer, Papillary 4 Neoplasm Metastasis 4 Leukemia, Hairy Cell 4 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Carcinoma, Non-Small-Cell Lung 3 Thyroid Carcinoma, Anaplastic 2 Skin Neoplasms 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Hematologic Neoplasms 2 Glioma 2 Colorectal Neoplasms 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Thyroid cancer, follicular 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Ovarian Neoplasms 1 Osteosarcoma 1 Noonan syndrome 3 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1

Interventions

Azacitidine 29 venetoclax 21 Cyclophosphamide 17 Whole-Body Irradiation 14 fludarabine phosphate 13 Biopsy 13 fludarabine 12 Tacrolimus 12 Specimen Handling 12 Mycophenolic Acid 11 Decitabine 11 Cytarabine 10 Stem Cell Transplantation 9 Peripheral Blood Stem Cell Transplantation 9 Injections 8 decitabine and cedazuridine drug combination 7 Melphalan 7 Busulfan 6 X-Rays 5 Hematopoietic Stem Cell Transplantation 5 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Cyclosporine 4 sabatolimab 3 olutasidenib 3 enasidenib 3 cedazuridine 3 Sirolimus 3 Rituximab 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡